Page last updated: 2024-10-25

cyproheptadine and Lung Neoplasms

cyproheptadine has been researched along with Lung Neoplasms in 4 studies

Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research Excerpts

ExcerptRelevanceReference
"We reported two cases of hepatocellular carcinoma (HCC) with lung metastases who were treated with a combination of thalidomide and cyproheptadine."7.78Unexpected remission of hepatocellular carcinoma (HCC) with lung metastasis to the combination therapy of thalidomide and cyproheptadine: report of two cases and a preliminary HCC cell line study. ( Chen, SC; Feng, CW; Feng, YM; Hsu, CD, 2012)
"Osimertinib is a tyrosine kinase approved and effective in treating lung adenocarcinomas that have one of several common activating mutations in epidermal growth factor receptor."6.72OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs. ( Halatsch, ME; Kast, RE; Rosell, R, 2021)
"We reported two cases of hepatocellular carcinoma (HCC) with lung metastases who were treated with a combination of thalidomide and cyproheptadine."3.78Unexpected remission of hepatocellular carcinoma (HCC) with lung metastasis to the combination therapy of thalidomide and cyproheptadine: report of two cases and a preliminary HCC cell line study. ( Chen, SC; Feng, CW; Feng, YM; Hsu, CD, 2012)
"Osimertinib is a tyrosine kinase approved and effective in treating lung adenocarcinomas that have one of several common activating mutations in epidermal growth factor receptor."2.72OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs. ( Halatsch, ME; Kast, RE; Rosell, R, 2021)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Kast, RE1
Halatsch, ME1
Rosell, R1
Feng, YM1
Feng, CW1
Chen, SC1
Hsu, CD1
Hilgard, P1
Heller, H1
Schmidt, CG1
Brune, GG1
Sill, V1

Reviews

1 review available for cyproheptadine and Lung Neoplasms

ArticleYear
OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs.
    Cells, 2021, 05-10, Volume: 10, Issue:5

    Topics: Acrylamides; Adenocarcinoma of Lung; Aniline Compounds; Animals; Azithromycin; Carcinoma, Non-Small-

2021

Other Studies

3 other studies available for cyproheptadine and Lung Neoplasms

ArticleYear
Unexpected remission of hepatocellular carcinoma (HCC) with lung metastasis to the combination therapy of thalidomide and cyproheptadine: report of two cases and a preliminary HCC cell line study.
    BMJ case reports, 2012, Oct-12, Volume: 2012

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Survival; Cyprohepta

2012
The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL).
    Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology, 1976, Aug-30, Volume: 86, Issue:3

    Topics: Animals; Aspirin; Bencyclane; Cyproheptadine; Dipyridamole; Female; Lung Neoplasms; Male; Mice; Mice

1976
[Carcinoid syndrome. Tryptophan metabolism--pathogenesis of concomitant symptoms--combination of tumours].
    Munchener medizinische Wochenschrift (1950), 1972, May-19, Volume: 114, Issue:20

    Topics: Adenocarcinoma; Aprotinin; Carcinoid Tumor; Chondroma; Colonic Neoplasms; Cyproheptadine; Humans; Hy

1972